RS
REGN icon

Rakuten Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Rakuten Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.86K Sell
11
-27
-71% -$18.4K ﹤0.01% 512
2026
Q1 		$29.4K Buy
38
+22
+138% +$16.8K 0.01% 305
2025
Q4 		$12.3K Sell
16
-32
-67% -$21.7K ﹤0.01% 405
2025
Q3 		$27K Sell
48
-91
-65% -$51.5K 0.01% 293
2025
Q2 		$73K Sell
139
-48
-26% -$26.8K 0.03% 193
2025
Q1 		$119K Buy
187
+148
+379% +$102K 0.06% 147
2024
Q4 		$27.8K Buy
39
+15
+63% +$12.6K 0.01% 269
2024
Q3 		$25.2K Buy
24
+19
+380% +$21.1K 0.01% 236
2024
Q2 		$5.25K Hold
5
– – ﹤0.01% 389
2024
Q1 		$4.81K Buy
5
+2
+67% +$1.9K ﹤0.01% 403
2023
Q4 		$2.63K Buy
+3
New +$2.47K ﹤0.01% 410

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rakuten Securities's REGN Position: Q2 2026 in Review

Rakuten Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 71% in Q2 2026, selling an estimated $18.4K and leaving 11 shares worth $6.86K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Rakuten Securities first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $119K in Q1 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Rakuten Securities held 11 shares of Regeneron Pharmaceuticals worth $6.86K as of Q2 2026.
  • Rakuten Securities sold 27 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $18.4K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #512 holding.
  • Rakuten Securities first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Regeneron Pharmaceuticals position peaked at $119K in Q1 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.